Evidence map›Paper›PMID 40493617›Full record

ArticlePloS one2025

Characterization of the genomic landscape of canine oral osteosarcoma reveals similarities with appendicular osteosarcoma.

Christopher Husted, Sarah Adrianowycz, Cornelia Peterson, Suzanne Bartholf DeWitt, Elinor K Karlsson, William Eward, Jason A Somarelli, Kate Megquier, Heather L Gardner

Abstract read
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Integrated Multiomic Profiling Enhances Risk Stratification and Prognostication in Canine Osteosarcoma.Clinical cancer research : an official journal of the American Association for Cancer Research · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Christopher HustedUMass Chan Medical School, Worcester, Massachusetts, United States of America.
Sarah AdrianowyczTufts University Cummings School of Veterinary Medicine, North Grafton, Massachusetts, United States of America.
Cornelia PetersonTufts University Cummings School of Veterinary Medicine, North Grafton, Massachusetts, United States of America.ORCID https://orcid.org/0000-0001-6550-1883
Suzanne Bartholf DeWittDepartment of Medicine, Duke University Medical Center, Durham, North Carolina, United States of America.ORCID https://orcid.org/0000-0001-7593-3567
Elinor K KarlssonUMass Chan Medical School, Worcester, Massachusetts, United States of America.
William EwardDepartment of Orthopaedic Surgery, Duke University Medical Center, Durham, North Carolina, United States of America.
Jason A SomarelliDepartment of Medicine, Duke University Medical Center, Durham, North Carolina, United States of America.
Kate MegquierBroad Institute of MIT and Harvard, Cambridge, Massachusetts, United States of America.ORCID https://orcid.org/0000-0002-1458-0865
Heather L GardnerTufts University Cummings School of Veterinary Medicine, North Grafton, Massachusetts, United States of America.

Funding

The OSU Center for Clinical and Translational Science: Advancing Today's Discoveries to Improve HealthUL1TR002733 · NCATS · OHIO STATE UNIVERSITY · PI RINGEL, MATTHEW D · 2018 to 2022
$28.9M
Transforming family dogs into a powerful and accessible model for human cancerR37CA218570 · NCI · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI KARLSSON, ELINOR · 2018 to 2022
$3.2M
Leveraging canine spontaneous cancer to optimize the power of blood biopsyR01CA255319 · NCI · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI KARLSSON, ELINOR, LONDON, CHERYL A · 2021 to 2025
$3.1M
Elucidating the therapeutic utility of targeting metabolic dependencies in osteosarcomaK01OD028268 · OD · TUFTS UNIVERSITY BOSTON · PI GARDNER, HEATHER LYNN · 2020 to 2024
$631k
Investigating the Role of MYC in Meibomian Gland OncogenesisK01OD034451 · OD · TUFTS UNIVERSITY BOSTON · PI Cornelia Ward Mary Peterson · 2024 to 2026
$380k
Advancing precision medicine through development of the canine comparative cancer modelF32CA247088 · NCI · BROAD INSTITUTE, INC. · PI MEGQUIER, KATHERINE JANE · 2020 to 2022
$205k
NCATS NIH HHS UL1 TR002733NCI NIH HHS F32 CA247088NCI NIH HHS R01 CA255319NCI NIH HHS R37 CA218570NIH HHS K01 OD028268NIH HHS K01 OD034451
6 · The paper itself

Abstract

Osteosarcoma (OS) is the most common bone tumor in both dogs and humans. It predominantly occurs in the appendicular skeleton, with about 25% of cases occurring within the axial skeleton. Progression of local disease is often the life-limiting factor for patients with axial OS, in contrast to appendicular OS, where local disease is addressed surgically, and metastatic disease remains the primary obstacle. While OS is a rare human cancer, limiting the availability of samples, its higher incidence in dogs provides a valuable comparative model for study. Both canines and humans share commonalities in clinical presentation, but dogs have an accelerated progression. Similarly, complex structural genetic changes define appendicular OS in both dogs and people, but it is unclear whether the genomic landscape of axial OS exhibits different alterations that may separate it from appendicular OS. We performed pilot whole genome sequencing of canine primary oral (maxillary or mandibular) OS tumors (n = 8) and matched normal tissue. We found that the genetics of canine oral OS largely parallel the genetics of canine appendicular OS, including an overall low number of recurrent point mutations affecting the same gene (TP53 and SETD2, 3/8 samples). Structural variants dominated the landscape of mutational changes, with recurrent variants in DMD (4/8) and DLG2 (3/8) found at a similar incidence to appendicular OS. This pilot suggests genomic similarities between oral and appendicular OS.

Indexed as

Bone NeoplasmsDog DiseasesMouth NeoplasmsOsteosarcomaAnimalsDogsGenomicsMaleWhole Genome Sequencing

Identifiers

PMID40493617
PMCPMC12151373

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.